Idelalisib

Idelalisib : Inhibitor of PIK3CD

Structure

Information

  • PIK3CD
  • Inhibitor
  • up to 1 uM

In Vitro Validations

Uniprot ID: O00329
Target Class: Kinase
Target SubClass: PI3/PI4 family
Potency: IC50
Potency Value: 2.5 nM
Potency Assay: Enzymatic assay using recombinant protein at Km ATP
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Phosphatidylinositol 4,5-bisphosphate 3-kinase cat ...

DOI Reference: 10.1182/blood-2010-03-275305

In Cell Validations

In Vivo Data

No in Vivo Validations

Off-Target Selectivity Assesments

Potency assay, off target (cells): In cell-based assays, CAL-101 had 240- to 2500-fold selectivity for p110δ over the other class I PI3K isoforms.
Potency assay (off target): 40- to 300-fold more selective for p110δ relative to other PI3K class I enzymes (IC50 p110δ = 2.5nM; p110α, p110β, and p110γ IC50 were 820, 565, and 89nM, respectively, measured at Km ATP for respective kinase in an enzymatic assay); greater selectivity (400- to 4000-fold) was seen against related kinases C2β, hVPS34, DNA-PK, and mTOR, whereas no activity was observed against a panel of 402 diverse kinases at 10μM (Ambit KinomeScan, data not shown).
I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating

SERP Comments:

This compound is likely to be a pan-p110 inhibitor unless used at <100 nM in cells

(last updated: 3 Jul 2023 )

SERP Ratings

In Cell Rating

(last updated: 18 Jul 2023 )

SERP+ Ratings

In Cell Rating

SERP+ Comments:

This is a highly selective inhibitor.

(last updated: 17 Jun 2024 )